Medtronic (MDT) Revenue — Quarter Ended Jul 26, 2024
Revenue declined from the immediately preceding quarter but rose compared with the same quarter one year earlier. The sequential drop reflects a typical seasonal pattern, while the year-over-year gain indicates underlying business momentum.
Key takeaway
Quarter ended Jul 26, 2024 · FY2025 Q1
Revenue declined from the immediately preceding quarter but rose compared with the same quarter one year earlier. The sequential drop reflects a typical seasonal pattern, while the year-over-year gain indicates underlying business momentum.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$7.9B
Revenue reported for this quarter.
Quarter-over-quarter
-7.8%
Change from the immediately preceding quarter.
Year-over-year
+2.8%
Change from the comparable year-ago quarter.
Trailing four quarters
$32.6B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Oct 27, 2023 | $8B | +5.3% |
| Jan 26, 2024 | $8.1B | +4.7% |
| Apr 26, 2024 | $8.6B | +0.5% |
| Jul 26, 2024 | $7.9B | +2.8% |
Revenue performance
Reported revenue decreased from the preceding quarter, driven by lower sales volumes across certain segments. Compared with the same period last year, revenue increased, supported by improved market demand and product adoption.
Quarterly comparison
The current quarter revenue was lower than the prior quarter, marking a sequential contraction of approximately mid-single digits. Conversely, it exceeded the year-ago level, reversing a prior-year decline.
What to watch
Monitor whether the company can sustain year-over-year revenue growth amid competitive pressures and regulatory uncertainties highlighted in the filing.